Trademarkia Logo

Canada

C$
Trademark Search in Canada
U-Load

View On IC.GC.CA

U-Load
APPROVED

on 2 Apr 2025

Last Applicant/ Owned by

Immudex ApS

Bredevej 2ADK-2830 Virum

DK

Serial Number

2168491 filed on 12th Nov 2021

Correspondent Address

FURMAN IP LAW & STRATEGY PC

260-10 Research DriveOffice D/EREGINA

SASKATCHEWAN

CA

S4S7J7

U-Load

Trademark usage description

chemicals used in medical diagnostics in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, tb vaccines, hiv-vaccines, cmv-v Read More

Classification Information

Class [001]
Chemicals used in medical diagnostics in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; diagnostic preparations for medical-scientific research use; diagnostic reagents for medical-scientific research use; diagnostic reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; research reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; diagnostic reagents for medical-scientific research use in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumours and tissue, and for analysis of infectious diseases, auto-immunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; biochemical reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, Lyme disease vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring.

Classification kind code

11

Class [005]
Preparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious disease; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemico-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes for use in the diagnosis and treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases related to immune suppression, autoimmune disease and infectious diseases; reagents for medical and veterinary purposes for use in the diagnosis and treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; human vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccines, immunotherapeutics and cellular therapies, cancer vaccines and immunotherapeutics, Lyme disease vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy and other therapy, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and infectious diseases; preparations for analysis for medical diagnostic purposes in relation to medical procedures and diagnosis, namely transplantation, immune monitoring, and vaccines and T-cell monitoring; Chemicals used in medical treatment in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for treatment of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; diagnostic reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue; diagnostic chemical reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumours and tissue, and for analysis of infectious diseases, auto immunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; diagnostic kits for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; assays for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring; chemical reagents for use in medical diagnostics applications in the field of vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB vaccines, HIV-vaccines, CMV-vaccines and other vaccines, or for use in connection with therapy and immunotherapy, cancer therapy, cancer immunotherapy, for analysis or treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis of infectious diseases, autoimmunity and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring.

Classification kind code

11

Mark Details

Serial Number

2168491

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 23rd Jun 2023		Search Recorded
Submitted for opposition 20
on 23rd Jun 2023		Examiner's First Report
Submitted for opposition 223
on 23rd Jun 2023		Total Provisional Refusal
Submitted for opposition 48
on 6th Mar 2023		Agent Changed
Submitted for opposition 256
on 26th Dec 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 24th Feb 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 23rd Feb 2022		Created
Submitted for opposition 31
on 23rd Feb 2022		Formalized
Submitted for opposition 228
on 12th Nov 2021		International Registration
Submitted for opposition 30
on 12th Nov 2021		Filed